By Business/Source
Currency:USD
2024/FY
Stock NameRevenueRatio
Clinical laboratory goods39.37M63.96%
Point-of-Care products17.43M28.32%
Clinical Laboratory Services4.75M7.72%
By Country/Region
Currency:USD
2024/FY
Stock NameRevenueRatio
Americas29.92M48.60%
Asia / Africa24.78M40.25%
Europe (including Ireland)6.86M11.15%